Laboratorios Farmaceuticos Rovi, SA

ROVI

Equity

ISIN ES0157261019 / Valor 3591807

BME Bolsas y Mercados Espanoles - Renta Variable (2026-02-26)

EUR 84.60+3.11%

Laboratorios Farmaceuticos Rovi, SA
UMushroom community rating:

3.00 1 votes No rating yet

NegativeNeutralPositive

About company

Laboratorios Farmaceuticos Rovi, SA, established in 1946, is a Spanish pharmaceutical company that specializes in the research, development, manufacture, and marketing of pharmaceutical products. Over the decades, the company has expanded its operations beyond Spain, achieving a significant international presence. Rovi's product portfolio includes both proprietary and licensed pharmaceutical products, with a notable focus on low-molecular-weight heparins, such as Bemiparin. The company has also ventured into contract manufacturing, offering services like production, filling, and packaging, particularly specializing in prefilled syringes and solid oral forms. Rovi places a strong emphasis on research and development, maintaining a solid and low-risk approach to innovation. In recent years, the company has been involved in significant agreements and collaborations with global pharmaceutical firms, and it played a role in the manufacturing process for the Moderna COVID-19 vaccine.

Summarized from source with an LLMView SourceSector: Healthcare

Latest Results ():

Summarized from source with an LLMView Source

Key figures

54.4%1Y

105%3Y

87.2%5Y

Performance

24.2%1Y

29.3%3Y

33.5%5Y

Volatility